Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy.
about
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.New insights on Schwann cell developmentEnergy failure: does it contribute to neurodegeneration?The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In VivoNew Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.Schwann cell interactions with axons and microvessels in diabetic neuropathy.The tumour suppressor LKB1 regulates myelination through mitochondrial metabolism.Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance.Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neuronsLoss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy.Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function.Myelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosisMitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses.Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study.Concepts for regulation of axon integrity by enwrapping glia.Mitochondrial dysfunction in central nervous system white matter disorders.Effect of insulin-induced hypoglycaemia on the peripheral nervous system: focus on adaptive mechanisms, pathogenesis and histopathological changes.A unified cell biological perspective on axon-myelin injury.Schwann cell myelinationThe Glia Response after Peripheral Nerve Injury: A Comparison between Schwann Cells and Olfactory Ensheathing Cells and Their Uses for Neural Regenerative Therapies.Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells.Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?Neurological consequences of obesity.Mitochondrial dysfunction in glial cells: Implications for neuronal homeostasis and survival.Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy.Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.Oxidative stress response to acute hypobaric hypoxia and its association with indirect measurement of increased intracranial pressure: a field study.The role of oxidative stress in nervous system aging.Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome.The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline.Tonsil-Derived Mesenchymal Stem Cells Differentiate into a Schwann Cell Phenotype and Promote Peripheral Nerve Regeneration.Mitochondrial Membrane Potential-dependent Endoplasmic Reticulum Fragmentation is an Important Step in Neuritic Degeneration.Interorganelle Communication between Mitochondria and the Endolysosomal System.Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.Acetyl-CoA production from pyruvate is not necessary for preservation of myelin.Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.
P2860
Q27330087-936BB092-065E-4EF3-B636-A80D971F11EAQ28083538-915AF855-2562-4638-8524-C9597B9EA057Q28389950-CAFBF8F3-1B5D-4BF4-8220-57DCACF920B2Q28551366-C9A70369-5D58-4F49-9415-81EC0DCD7628Q30235132-0920F59D-269C-4FFF-9718-A38985F40A8CQ30238727-620EEA23-AE14-4AA8-A379-361D8D04D304Q30650481-7225D7F7-7F17-43D6-92C2-6E01C089E342Q30656970-CD5B5E84-DB42-4F3C-B122-895593F554DDQ33865342-9724718D-6549-43D8-A46C-04BECD1E5E18Q34764035-F58A276E-CB38-4B28-84D8-0FB9B8F979E8Q35029938-929F6C6F-DA99-47D7-B133-98CE9EBAE630Q35126311-7C993D6E-2307-430B-B1F4-67B8BD5987ECQ37262107-328C6E38-C757-4535-84D0-C1E6BCCAAEF7Q37265491-E9E5F750-706D-4E43-ADCA-341D4D55F6E2Q37290153-80CF93F7-F076-4165-81FE-5CF8A4ACFBECQ37708207-D6872333-3909-4D37-A2EC-927FCCFDE4C1Q38175969-8EC6C067-5930-4D4D-A972-3F88DE095866Q38215315-D82ADDF8-7F7F-4579-8275-5C5F333EAF94Q38219681-D30E1B07-D58E-49F1-9213-E909E7DB35C5Q38237032-6EF03928-B0EA-4DA9-B154-EE8CD97A51E9Q38520894-0AAB2C37-94FC-4D1F-B364-4F068826EE3FQ38763357-3CE31672-F4AF-4C3E-9F8A-1745EE028DC5Q38957347-2C0DBDDB-76E8-40CF-A16C-31639EDFAFCEQ39107278-FC429D04-ACA0-4B0B-9453-40451A90062DQ39132982-3D579445-9030-4491-89D5-B4FDD6D240F5Q39306482-44EA7781-3015-41A6-8F8B-AC7725A47F44Q39401287-8245EC34-7535-41AE-B730-7C204E1BB776Q40227033-A4A278E0-2011-4E2E-8040-8D2F16C236E1Q40515513-58C738A6-B8F6-4125-9EF2-0C7D8828FB1AQ40985536-7085E1EB-9A45-467B-967B-6BF274F77FA9Q41298557-9B1AE95D-D682-4235-ADB6-C848B3842206Q41419380-4027F537-5E9D-4169-A6BA-5D0512EA9D42Q42164137-9EA76E65-D7F6-4328-98EB-288F7A111FCCQ42359883-474FF352-24B2-4D9B-B4BA-114942832608Q46563454-434D2CBF-71CA-46DC-BB08-1C8FD646E7BEQ47098553-B8515DE1-59E6-4707-A5EA-61AE8DCA435BQ47363157-EAFDBD38-A77A-48DA-A35D-936DE5C138F7Q47633073-7AE7BF95-365D-4041-A67F-0EA49C5D67A8Q48058858-DAE0FD38-F017-4E66-ACA2-4D5E66FB458DQ49825852-5C59B1E3-AE15-49AF-B322-4EEED584A332
P2860
Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Aberrant Schwann cell lipid me ...... n degeneration and neuropathy.
@ast
Aberrant Schwann cell lipid me ...... n degeneration and neuropathy.
@en
type
label
Aberrant Schwann cell lipid me ...... n degeneration and neuropathy.
@ast
Aberrant Schwann cell lipid me ...... n degeneration and neuropathy.
@en
prefLabel
Aberrant Schwann cell lipid me ...... n degeneration and neuropathy.
@ast
Aberrant Schwann cell lipid me ...... n degeneration and neuropathy.
@en
P2093
P2860
P1433
P1476
Aberrant Schwann cell lipid me ...... on degeneration and neuropathy
@en
P2093
Amy Strickland
Andreu Viader
Cayce S Workman
Richard W Gross
Sungsu Kim
P2860
P304
P356
10.1016/J.NEURON.2013.01.012
P407
P577
2013-03-01T00:00:00Z